Results 191 to 200 of about 5,089 (214)

From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants. [PDF]

open access: yesJ Med Chem
Lemieux G   +17 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Hunting the subset-specific genes of neuroblastoma: Expression profiling and differential screening of the full-length-enriched oligo-capping cDNA libraries

Medical and Pediatric Oncology, 2000
Neuroblastoma (NBL) has a distinct nature in different prognostic subgroups.To understand the molecular mechanism of NBL's genesis and biology as well as that of the neural crest development, we constructed full-length-enriched cDNA libraries by an oligo-capping method from two different subsets of primary NBL, one with favorable biology and the other ...
M, Ohira   +14 more
openaire   +3 more sources

Association between favorable neuroblastoma and high expression of the novel metalloproteinase gene,nbla3145/XCE, cloned by differential screening of the full-length-enriched oligo-capping neuroblastoma cDNA libraries

Medical and Pediatric Oncology, 2000
The biology of neuroblastoma (NBL) is at least partly regulated by neurotrophic factors and their receptors.To identify novel NBL-related genes that affect growth, differentiation, and programmed cell death of the tumor, we constructed full-length-enriched cDNA libraries by oligo-capping method.Semi-quantitative and quantitative real-time RT-PCR showed
T, Kawamoto   +10 more
openaire   +2 more sources

Social determinants of health and US cancer screening interventions: A systematic review

Ca-A Cancer Journal for Clinicians, 2023
Ariella R Korn   +2 more
exaly  

Cancer screening in the United States, 2013

Ca-A Cancer Journal for Clinicians, 2013
Robert A Smith   +2 more
exaly  

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

Ca-A Cancer Journal for Clinicians, 2020
Elizabeth T H Fontham   +2 more
exaly  

Home - About - Disclaimer - Privacy